Cite

HARVARD Citation

    Hilbers, M. et al. (2021). Real-life data for first-line combination immune-checkpoint inhibition and targeted therapy in patients with melanoma brain metastases. European journal of cancer. pp. 149-163. [Online]. 
  
Back to record